Viridian Therapeutics Inc (VRDN) is a biotechnology company listed on US.
Latest reported VRDN revenue for 2026-06-30 was $425.0K. Net income was -$232.0M. VRDN currently screens at market cap $1.39B.
Use this VRDN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VRDN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VRDN SEC filings page. Lician reads the product cache first so this HTML stays unique to Viridian Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full VRDN income, balance, and cash tables.